Feature
GLP-1 Patches: What's Inside and Do They Work?
No GLP-1 patch contains a GLP-1 drug. What the stickers hold (mostly berberine), whether it can cross skin, and what a 2026 review of 25 products found.
By Priya Raman
Nutrition & Microbiome Editor ·
Contents
CoreAge Rx — GLP-1 Support
From $23.83/bottle
Transparent, no-prescription daily probiotic for gut and metabolic support — three strains plus prebiotic fiber.
Shop CoreAge GLP-1 Support- Category
- GLP-1 support · telehealth
- Formulation
- 3 strains + prebiotic fiber
- Access
- No Rx
Advertising disclosure · we may earn a commission at no extra cost to you. Partners are listed first on our comparisons, and this is one.
Eden
A large compounded-GLP-1 telehealth platform with flat per-dose pricing on every page — and a price that depends on which of its own pages you enter through.
See if you qualify with EdenShort answer: no "GLP-1 patch" sold online contains semaglutide, tirzepatide or any other GLP-1 drug, and none has been tested in a human weight-loss trial. The stickers hold plant extracts, most often berberine, and the only peer-reviewed look at the category found 25 products with no published lab testing and labels that broke the rules for supplements. If you want what a GLP-1 drug does, a patch is not a cheaper route to it.
That verdict needs some unpacking, because the products borrow a real drug class's name and a real line of research (microneedle patches that do deliver GLP-1 drugs in animals). Here is what is inside them, what the skin lets through, and what better-evidenced options look like.
Does any GLP-1 patch contain a GLP-1 drug?
No. The FDA told TODAY.com in September 2025 that "there are no FDA-approved GLP-1 patches," and added that there are "no FDA-approved drug products containing berberine" either 10. The approved GLP-1 medicines are injections or tablets, prescribed and dispensed through a pharmacy. Anything sold as a sticker on a marketplace or through a social ad is something else using the name.
That "something else" is usually marketed as a dietary supplement, which creates a second problem. Under the federal law that governs supplements, a dietary supplement is a product "intended for ingestion," and the FDA's own guidance says supplements "must be swallowed" 9. A patch is not swallowed. The authors of the only published review of these products made exactly that point: because supplements must be taken by mouth, they concluded that every transdermal "natural GLP-1" supplement they found is being sold illegally 1.
Same name, different products
| Approved GLP-1 drugs | Consumer "GLP-1 patch" | Research microneedle patch | |
|---|---|---|---|
| Contains | Semaglutide, tirzepatide and others | Berberine, glutamine, cinnamon, pomegranate, other extracts | Liraglutide or semaglutide |
| How it gets in | Injection or specially formulated tablet | Stuck on skin; no human absorption data | Tiny needles carry the drug past the skin barrier |
| FDA approved | Yes, by prescription | No | No (in development) |
| Human weight data | About 15% to 21% average loss in large trials | None | None yet (rats and minipigs) |
What is actually inside the patches?
In early 2026, researchers at the University of Connecticut School of Pharmacy published the first systematic look at the category in Annals of Pharmacotherapy. They identified 24 transdermal patches and 1 transdermal gel sold as "natural GLP-1" supplements 1. Each product listed an average of 7 natural ingredients (give or take 4), and the most common were:
- Berberine, a bitter plant alkaloid with real oral research behind it for blood sugar
- Glutamine or glutamate, amino acids
- Cinnamon
- Pomegranate
Other listings varied from brand to brand. The review also found that no product posted a certificate of analysis (the third-party lab report that confirms what is in a batch and how much), many were missing the standard FDA disclaimer that supplements must carry, and many used advertising the authors described as deceptive. Several products had 1- to 2-star customer ratings with comments describing no effect or side effects 1.
None of those ingredients is a GLP-1 drug, and none is a GLP-1 molecule. At most, some of them have been studied (by mouth) for nudging the body's own hormone and glucose signals. That is the same "natural GLP-1" idea we take apart in our gut health and natural GLP-1 evidence review: your gut does make GLP-1, and food and fiber can raise it a little, but nowhere near drug levels.
Can berberine get through your skin?
This is the question the marketing skips. Skin is built to keep things out. Its outer layer, the stratum corneum, blocks most molecules, and a widely cited rule of thumb in dermatology holds that a compound generally needs a molecular weight under about 500 daltons to be absorbed through intact skin. Every drug in an approved transdermal patch at the time that rule was proposed fit under that line 2.
That rule cuts two ways for GLP-1 patches:
- A real GLP-1 drug could never work this way. Semaglutide is a peptide of roughly 4,114 daltons, eight times over the threshold 11. That is the reason the approved forms are injections or a specially formulated tablet, and the reason drug developers who want a semaglutide patch reach for microneedles (more on that below).
- Berberine is small enough to be plausible on paper. The berberine molecule weighs about 336 daltons 12, so it is not ruled out by size alone. But "small enough" is not the same as "absorbed in a useful amount." Getting a dose through skin depends on how much drug is loaded, the carrier, the patch area, how long it stays on, and how readily the molecule dissolves into skin oils. We could not find a single published human study measuring blood levels of berberine from any consumer GLP-1 patch. The laboratory work on berberine and skin uses engineered carriers (liposomes, gels, dissolving microneedles) to treat skin conditions such as psoriasis, not to raise blood levels for weight loss 13.
Even swallowed berberine is hard to get into the bloodstream. In rats, most of an oral dose is cleared by the gut wall and liver before it reaches circulation, which is one reason its blood levels are so low 3. Its effects in people are thought to start in the gut, which a patch on your arm bypasses entirely. We cover that gut-first story, including the microbiome changes researchers link to oral berberine, in berberine and your gut microbiome.
What does berberine do when you actually swallow it?
Less for weight than the "nature's Ozempic" label implies. A 2020 meta-analysis of 10 clinical trials of oral berberine found small reductions in BMI (about 0.3 kg/m²) and waist circumference (about 2.8 cm), but no significant change in body weight itself 4. That is the ingredient at its best, taken by mouth in studied doses. A patch would have to deliver comparable amounts through skin to match even that modest result, and nobody has shown that it does.
Compare that with the drugs whose name the patches borrow. In the STEP 1 trial, adults taking weekly semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks 5. In SURMOUNT-1, tirzepatide produced average losses of 15.0% to 20.9% over 72 weeks, depending on dose 6.
GLP-1 patch claims, rated
- Patch contains a GLP-1 drugNo evidence
None do; the FDA says no GLP-1 patch is approved.
- Berberine patch → weight loss in peopleNo evidence
No human trial of any consumer GLP-1 patch has been published.
- Berberine crosses skin in useful amounts from a patchNo evidence
Small enough on paper (about 336 Da), but no human blood-level data for any consumer patch.
- Oral berberine → small BMI and waist changesWeak evidence
Meta-analysis of 10 trials: BMI about −0.3, waist about −2.8 cm, body weight unchanged (Xiong 2020).
- Microneedle patches can deliver real GLP-1 drugsWeak evidence
Shown in rats and minipigs with liraglutide and semaglutide; not yet in people (Lin 2025; Woo 2025).
Is anyone making a real GLP-1 patch?
Yes, in research labs, and the contrast is instructive. Scientists are developing microneedle patches: arrays of tiny needles, often made of a material that dissolves in skin, that carry a GLP-1 drug past the stratum corneum instead of hoping it diffuses through.
- A dissolving microneedle patch loaded with liraglutide (an older GLP-1 drug) delivered the drug into the bloodstream of rats and minipigs, reaching 69.8% and 46.3% of the exposure seen with an under-the-skin injection, with glucose effects in diabetic rats similar to injection 7.
- A hyaluronic-acid microneedle patch carrying semaglutide lowered blood glucose, A1c and body weight in diabetic rats, with effects the authors described as comparable to injected semaglutide 8.
Both are animal studies. Neither product is approved or for sale, and neither resembles a herbal sticker. They contain the actual drug, they pierce the skin's barrier mechanically, and they were measured with blood tests. Consumer "GLP-1 patches" do none of those things. When an ad cites "patch technology" or "transdermal GLP-1 research," this is the research it is borrowing from.
Are GLP-1 patches safe to try?
They are unlikely to do much, which is not the same as being risk-free. The concerns the 2026 review raised are practical:
- Unknown contents and doses. With no certificate of analysis, you cannot confirm what is in the adhesive or how much 1.
- Skin reactions. Adhesives and plant extracts can irritate or sensitize skin, and the review noted customer reports of adverse events 1.
- Interactions, if anything is absorbed. Berberine is studied precisely because it lowers blood sugar, so it can stack with diabetes medicines. If you take metformin, insulin or another glucose-lowering drug, talk to your prescriber before adding berberine in any form.
- The opportunity cost. Money spent on a product with no human data is money not spent on something with evidence, and time spent waiting for a sticker to work is time a treatable condition goes unmanaged.
What works better than a patch?
It depends on what you were hoping the patch would do.
If you want the size of effect GLP-1 drugs produce, the only route is the drugs themselves, prescribed by a clinician who has reviewed your history. Many people now get them through telehealth programs, and prices and terms vary widely. We rank those programs on whether they show the price before the medical intake in our GLP-1 telehealth ranking, and by molecule in the compounded semaglutide ranking.
If you want gentle, food-level support for your own GLP-1, the strongest everyday lever is fermentable fiber, which gut bacteria turn into short-chain fatty acids that signal your gut's L-cells to release GLP-1. We explain that chain in how fiber raises your own GLP-1. Some probiotic products pair strains with prebiotic fiber for the same reason; we compare them, with the evidence for each, in the best metabolic probiotic rankings. Set expectations at "modest," not "drug-like."
If you are weighing other "natural GLP-1" products, the same questions apply to gummies, drops and powders: what is in it, at what dose, and has the finished product been tested in people? We run that test on a celebrity-backed version in our Lemme GLP-1 review.
Before you buy
Four questions for any "natural GLP-1" product
- Does it contain an actual GLP-1 drug? If it is sold without a prescription, the answer is no.
- Is there a certificate of analysis showing what is in each batch and how much?
- Has the finished product, not just one ingredient, been tested in people?
- Do you take metformin, insulin or other glucose-lowering drugs? Ask your prescriber before adding berberine in any form.
The bottom line
"GLP-1 patch" is a name, not an ingredient. The products contain berberine and other plant extracts, not a GLP-1 drug; the FDA has approved no GLP-1 patch; and the only published review of the category found 25 products with no lab reports, missing disclaimers and claims that outrun any evidence 1. Berberine's own oral record for weight is small, and no study shows a patch delivers it through skin in useful amounts. Real GLP-1 patches exist only as microneedle prototypes tested in animals. If you want a GLP-1's effect, talk to a prescriber; if you want food-level support, start with fiber.
“No GLP-1 patch contains a GLP-1 drug. What the stickers hold (mostly berberine), whether it can cross skin, and what a 2026 review of 25 products found.”
Reader questions
Do GLP-1 patches contain semaglutide or tirzepatide?
No. Consumer GLP-1 patches contain plant extracts, most often berberine, plus ingredients such as glutamine, cinnamon and pomegranate. The FDA has said there are no FDA-approved GLP-1 patches. Semaglutide and tirzepatide are prescription injections (and, for semaglutide, a tablet).
Do GLP-1 patches work for weight loss?
There is no published human trial showing they do. The only peer-reviewed review of the category (25 products, 2026) found no certificates of analysis, missing FDA disclaimers and deceptive advertising. Even swallowed berberine, the main ingredient, produced only small changes in BMI and waist size in a meta-analysis of 10 trials, with no significant change in body weight.
Can berberine be absorbed through the skin?
Its molecule is small enough (about 336 daltons) that skin absorption is not ruled out by size alone, but no study has measured blood levels from a consumer GLP-1 patch. Laboratory work on berberine and skin uses engineered carriers and targets skin conditions, not weight.
Are there real GLP-1 patches in development?
Yes, as microneedle patches that carry an actual GLP-1 drug (liraglutide or semaglutide) past the skin barrier. They have worked in rats and minipigs but are not approved or sold. They are a different technology from herbal stickers.
Are GLP-1 patches safe?
Contents and doses are unverified, adhesives and extracts can irritate skin, and berberine interacts with glucose-lowering drugs if absorbed. If you take metformin, insulin or other diabetes medicines, ask your prescriber before using berberine in any form.
Sources
- White CM, Tai Z, Nuzi K (2026). Transdermal "Natural GLP-1" Dietary Supplements Violate Law and Place Patients at Risk.. The Annals of Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/41480958/
- Bos JD, Meinardi MM (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs.. Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/10839713/
- Liu YT, Hao HP, Xie HG, et al. (2010). Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats.. Drug Metabolism and Disposition. https://pubmed.ncbi.nlm.nih.gov/20634337/
- Xiong P, Niu L, Talaei S, et al. (2020). The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.. Complementary Therapies in Clinical Practice. https://pubmed.ncbi.nlm.nih.gov/32379652/
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity.. The New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. The New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Lin H, Liu J, Hou Y, et al. (2025). Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs.. Drug Delivery and Translational Research. https://pubmed.ncbi.nlm.nih.gov/38619705/
- Woo CR, Kim GL, Han HK (2025). Fabrication and Preclinical Evaluation of Hyaluronic Acid/Aminoclay Nanocomposite Microneedles for Noninvasive Delivery of Semaglutide in Anti-Obesity Therapy.. International Journal of Nanomedicine. https://pubmed.ncbi.nlm.nih.gov/41030572/
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements. FDA.gov. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- Pawlowski A (2025). Do 'GLP-1 Patches' Work for Weight Loss? Doctors Warn About Trend. TODAY. https://www.today.com/today/amp/rcna232201
- National Center for Biotechnology Information (2026). Semaglutide (CID 56843331). PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/56843331
- National Center for Biotechnology Information (2026). Berberine (CID 2353). PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/2353
- Shen S, Shen W, Wang L, et al. (2025). Berberine hydrochloride-loaded liposomes-in-hydrogel microneedles achieve the efficient treatment for psoriasis.. Materials Today Bio. https://pubmed.ncbi.nlm.nih.gov/40343170/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Also in this issue
- 01
GLP-1 Supplements: Do Any Over-the-Counter Ones Work?
No supplement contains a GLP-1 drug. What OTC 'GLP-1' products hold, what each ingredient did in human trials, and how small the effect is next to Rx.
Read - 02
Akkermansia muciniphila: What the Human Trial Showed
The one human RCT behind Akkermansia's metabolic reputation — what it actually found, and why it's promising but still small and exploratory.
Read - 03
Akkermansia: Live vs Pasteurized — Why the Dead Bacteria Worked
The twist in the Akkermansia story: heat-killed bacteria matched or beat the live form in humans. The science, and what it means for products.
Read - 04
Best Gut-Microbiome Tests (Viome, Zoe & More): What They Actually Measure
Viome, Zoe, Tiny Health, Thorne — an honest review of what consumer gut-microbiome tests measure, and why most results aren't yet clinically actionable.
Read - 05
Butyrate: Supplements, Foods & the Evidence
Sodium butyrate, calcium-magnesium butyrate, tributyrin, or just more fiber? An honest evidence review of butyrate's gut and metabolic claims.
Read - 06
Bifidobacterium Lactis B420 and Body Fat: What the Trial Shows
A 225-person, 6-month RCT found B420 cut body fat ~4% — but the headline result came from a post-hoc analysis. An honest look at the evidence.
Read